| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 |
Form 4: Gonen Ofer, Chief Executive Officer
Received 8,168 shares by exercise ($110K) |
| 12 Nov 2026 |
Form 4: Shamir Nachum, Director
Received 16,336 shares by exercise ($220K) |
| 12 Nov 2026 |
Form 4: Fox David Morton, Director
Received 6,534 shares by exercise ($88K) |
| 12 Nov 2026 | 6-K |
| 05 Nov 2026 | 6-K |
| 05 Nov 2026 | 424B5 |
| 03 Nov 2026 | FWP |
| 03 Nov 2026 | 424B5 |
| 02 Sep 2026 |
Form 4: Rubinstein Samuel, Director
Sold 525 shares ($6.68K) · Bought 525 shares ($6.63K) |
| 28 Aug 2026 |
Form 4: Hess Shmuel, COO & Chief Commercial Officer
Sold 1,865 shares ($24.2K) · Exercised 5,000 Stock Option (right to buy ordinary shares) · Sold 3,958 shares ($51.1K) · 1 more |
| 28 Aug 2026 | SCHEDULE 13G/A |
| 28 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | 6-K |
| 04 Jun 2026 |
Form 4: Shamir Nachum, Director
Bought 6,000 shares ($84K) |
| 02 Jun 2026 |
Form 4: Fox David Morton, Director
Bought 3,537 shares ($49.9K) |
| 01 Jun 2026 |
Form 4: Rubinstein Samuel, Director
Bought 150 shares ($2.15K) |
| 27 May 2026 | 6-K |
| 15 May 2026 | SCHEDULE 13G |
Loading...